For instance, the nuclear factor-kappaB (NF-B), and Hedgehog signaling play crucial roles in determining cellular neoplastic transformation [102-103]
Marzio L, Falcucci M, Ciccaglione AF, et al
(2025) GLP-1 Receptor Agonist Medications for Obesity and Type 2 Diabetes Treatment: A Rapid Review of Changes in Eating Behaviors and Eating Disorder Risk, Obesity Reviews Advocacy and Clinical Organizations National Eating Disorders Association (NEDA) GLP-1 Medications and Eating Disorders ANAD GLP-1 Medications & Eating Disorders Clinical and News Sources Medscape (April 2025) GLP-1 RAs in Eating Disorders: Promising or Perilous? NPR (February 2026) GLP-1 obesity drugs and eating disorders are not well understood yet National Geographic (November 2025) Doctors are worried about prescribing GLP-1s to certain patients NBC News (August 2024) Eating disorders rise amid popular weight loss medications Wegovy and Zepbound
A., Kristrom, B., Rosberg, S., Svensson, B
We also guide you in accessing manufacturer discounts and copay programs when available
